|
|
|
|
|
|
by sinenomine
1504 days ago
|
|
|
I think the neuroplasticity angle is vastly underestimated, and we should seek (and also design, research & fund if there is none) neuroplasticity-upregulating drugs & therapies. As far as this field goes, this is a remarkable paper: https://pubmed.ncbi.nlm.nih.gov/24348349/ |
|
|
2 groups of 12. (one person's data was lost).
No baseline pre-treatment data.
Each group did two trials: VPA then placebo, or vice versa. The VPA-first group did well on VPA, but the VPA-second group did not. Improvement was suggestive but slight.